The potential of stem cells in the treatment of cardiovascular diseases

Stem Cell Reviews and Reports

Volumn 9, Issue 6, 2013, Pages 814-832

  Bernal, Aurora ^a   Gálvez, Beatriz G ^a  

^a CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

Author keywords

Cardiac cell therapy; Cardiac progenitors; Cardiac stem cells; Cardiomyocytes

Indexed keywords

MAMMALIA;

EID: 84903663402     PISSN: 26293269     EISSN: 26293277     Source Type: Journal    
DOI: 10.1007/s12015-013-9461-4     Document Type: Article

References (162)

1. Kikuchi, K., & Poss, K. D. (2012). Cardiac regenerative capacity and mechanisms. Annual Review of Cell and Developmental Biology, 28, 719–741.
2. Oh, H., Bradfute, S. B., Gallardo, T. D., Nakamura, T., Gaussin, V., et al. (2003). Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infacrtion. Proc Nat Acad Sci, 100, 12313–12318.
3. Chen, L., Wang, Y., Pan, Y., Zhang, L., Shen, C., et al. (2013). Cardiac progenitor-derived exosomes protect ischemic myocardium from acute ischemia/reperfusion injury. Biochemical and Biophysical Research Communications, 431, 566–571.
4. Huang, C., Gu, H., Yu, Q., Manukyan, M. C., Poynter, J. A., et al. (2011). Sca-1+ cardiac stem cells mediate acute cardioprotection via paracrine factor SDF-1 following myocardial ischemia/reperfusion. PloS One, 6.
5. Laugwitz, K. L., Moretti, A., Lam, J., Gruber, P., Chen, Y., et al. (2005). Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature, 433, 647–653.
6. Linke, A., Müller, P., Nurzynska, D., Casarsa, C., Torella, D., et al. (2005). Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function. Proceedings of the National Academy of Sciences of the United States of America, 102, 8966–8871.
7. Messina, E., De Angelis, L., Frati, G., Morrone, S., Chimenti, S., et al. (2004). Isolation and and expansion of adult cardiac stem cells from human and murine heart. Circulation Research, 95, 911–921.
8. Itescu, S., Schuster, M. D., & Kocher, A. A. (2003). New directions in strategies using cell therapy for heart disease. J Mol Med (Berl), 81, 288–296.
9. Kikuchi, K., Holdway, J. E., Major, R. J., Blum, N., Dahn, R. D., et al. (2011). Retinoic acid production by endocardium and epicardium is an injury response essential for zebrafish heart regeneration. Developmental Cell, 20(3), 397–404.
10. Lepilina, A., Coon, A. N., Kikuchi, K., Holdway, J. E., Roberts, R. W., et al. (2006). A dynamic epicardial injury response supports progenitor cell activity during zebrafish heart regeneration. Cell, 127, 607–619.
11. Kikuchi, K., Holdway, J. E., Werdich, A. A., Anderson, R. M., Fang, Y., et al. (2010). Primary contribution to zebrafish heart regeneration by gata4(+) cardiomyocytes. Nature, 464, 601–605.
12. MacLellan, W. R., & Schneider, M. D. (2000). Genetic dissection of cardiac growth control pathways. Annual Review of Physiology, 62, 289–319.
13. Chien, K. R., & Karsenty, G. (2005). Longevity and lineages: toward the integrative biology of degenerative diseases in heart, muscle, and bone. Cell, 120(4), 533–544.
14. Rumyantsev, P. P. (1977). Interrelations of the proliferation and differentiation processes during cardiact myogenesis and regeneration. International Review of Cytology, 51, 186–273.
15. Laflamme, M. A., & Murry, C. E. (2011). Heart regeneration. Nature, 473, 326–335.
16. Anversa, P., Leri, A., & Kajstura, J. (2006). Cardiac regeneration. Journal of the American College of Cardiology, 47, 1769–1776.
17. Beltrami, A. P., Barlucchi, L., Torella, D., Baker, M., Limana, F., et al. (2003). Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell, 114, 763–776.
18. Urbanek, K., Cesselli, D., Rota, M., Nascimbene, A., De Angelis, A., et al. (2006). Stem cell niches in the adult mouse heart. Proceedings of the National Academy of Sciences of the United States of America, 103, 9226–9231.
19. Quaini, F., Urbanek, K., Beltrami, A. P., Finato, N., Beltrami, C. A., et al. (2002). Chimerism of the transplanted heart. The New England Journal of Medicine, 346, 5–15.
20. Kajstura, J., Urbanek, K., Perl, S., Hosoda, T., Zheng, H., et al. (2010). Cardiomyogenesis in the adult human heart. Circulation Research, 107, 305–315.
21. Oh, H., Taffet, G. E., Youker, K. A., Entman, M. L., Overbeek, P. A., et al. (2001). Telomerase reverse transcriptase promotes cardiac muscle cell proliferation, hypertrophy, and survival. Proceedings of the National Academy of Sciences of the United States of America, 98, 10308–10313.
22. Pasumarthi, K. B., Nakajima, H., Nakajima, H. O., Soonpaa, M. H., & Field, L. J. (2005). Targeted expression of cyclin D2 results in cardiomyocyte DNA synthesis and infarct regression in transgenic mice. Circulation Research, 96, 110–118.
23. Limana, F., Urbanek, K., Chimenti, S., Quaini, F., Leri, A., et al. (2002). bcl-2 overexpression promotes myocyte proliferation. Proceedings of the National Academy of Sciences of the United States of America, 99, 6257–6262.
24. Liao, H. S., Kang, P. M., Nagashima, H., Yamasaki, N., Usheva, A., et al. (2001). Cardiac-specific overexpression of cyclin-dependent kinase 2 increases smaller mononuclear cardiomyocytes. Circulation Research, 88, 443–450.
25. Chien, K. R. (2004). Stem cells: lost in translation. Nature, 428(6983), 607–608.
26. Di Trapani, M., Bassi, G., Ricciardi, M., Fontana, E., Bifari, F., et al. (2013). Comparative study of immune regulatory properties of stem cells derived from different tissues. Stem cells and development.
27. Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., et al. (1998). Embryonic stem cell lines derived from human blastocysts. Science, 282, 1145–1147.
28. Garry, D. J., & Olson, E. N. (2006). A common progenitor at the heart of development. Cell, 127, 1101–1104.
29. Nussbaum, J., Minami, E., Laflamme, M. A., Virag, J. A., Ware, C. B., et al. (2007). Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response. The FASEB Journal, 21, 1345–1357.
30. Behfar, A., Perez-Terzic, C., Faustino, R. S., Arrell, D. K., Hodgson, D. M., et al. (2007). Cardiopoietic programming of embryonic stem cells for tumor-free heart repair. The Journal of Experimental Medicine, 204, 405–420.
31. Takahashi, K., & Yamanaka, S. (2006). nduction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126, 663–676.
32. Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., et al. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 131(5), 861–872.
33. Nam, Y. J., Song, K., Luo, X., Daniel, E., Lambeth, K., et al. (2013). Reprogramming of human fibroblasts toward a cardiac fate. Proceedings of the National Academy of Sciences of the United States of America, 11, 5588–5593.
34. Li, M., & Ikehara, S. (2013). Bone-marrow-derived mesenchymal stem cells for organ repair. Stem Cells Int, 2013, 132642.
35. Orlic, D., Kajstura, J., Chimenti, S., Jakoniuk, I., Anderson, S. M., et al. (2001). Bone marrow cells regenerate infarcted myocardium. Nature, 410, 701–705.
36. Toma, C., Pittenger, M. F., Cahill, K. S., Byrne, B. J., & Kessler, P. D. (2002). Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation, 105, 93–98.
37. Orlic, D., Kajstura, J., Chimenti, S., Limana, F., Jakoniuk, I., et al. (2001). Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proceedings of the National Academy of Sciences of the United States of America, 98, 10344–10349.
38. Yoon, Y. S., Wecker, A., Heyd, L., Park, J. S., Tkebuchava, T., et al. (2005). Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction. The Journal of Clinical Investigation, 115, 326–338.
39. Kajstura, J., Rota, M., Whang, B., Cascapera, S., Hosoda, T., et al. (2005). Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion. Circulation Research, 96, 127–137.
40. Mirotsou, M., Zhang, Z., Deb, A., Zhang, L., Gnecchi, M., et al. (2007). Secreted frizzled related protein 2 (Sfrp2) is the key Aktmesenchymal stem cell-released paracrine factor mediating myocardial survival and repair. Proceedings of the National Academy of Sciences of the United States of America, 104, 1643–1648.
41. Wang, M., Tan, J., Wang, Y., Meldrum, K. K., Dinarello, C. A., et al. (2009). IL-18 binding protein-expressing mesenchymal stem cells improve myocardial protection after ischemia or infarction. Proceedings of the National Academy of Sciences of the United States of America, 106, 17499–17504.
42. Uemura, R., Xu, M., Ahmad, N., & Ashraf, M. (2006). Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling. Circulation Research, 98, 1414–1421.
43. Bergmann, O., Bhardwaj, R. D., Bernard, S., Zdunek, S., Barnabé-Heider, F., et al. (2009). Evidence for cardiomyocyte renewal in humans. Science, 324, 98–102.
44. He, J. Q., Vu, D. M., Hunt, G., Chugh, A., Bhatnagar, A., et al. (2011). Human cardiac stem cells isolated from atrial appendages stably express c-kit. PloS One, 6(11), e27719.doi:101371/ journalpone0027719 E 6.
45. Towbin, J. A., & Bowles, N. E. (2002). The failing heart. Nature, 415, 227–233.
46. Gálvez, B. G., Covarello, D., Tolorenzi, R., Brunelli, S., Dellavalle, A., et al. (2009). Human cardiac mesoangioblasts isolated from hypertrophic cardiomyopathies are greatly reduced in proliferation and differentiation potency. Cardiovascular Research, 83, 707–716.
47. Galvez, B. G., Sampaolesi, M., Barbuti, A., Crespi, A., Covarello, D., et al. (2008). Cardiac mesoangioblasts are committed, selfrenewable progenitors, associated with small vessels of juvenile mouse ventricle. Cell Death and Differentiation, 15, 1417–1428.
48. Matsuura, K., Nagai, T., Nishigaki, N., Oyama, T., Nishi, J., et al. (2004). Adult cardiac Sca-1-positive cells differentiate into beating cardiomyocytes. The Journal of Biological Chemistry, 279, 11384–11391.
49. Smits, A. M., van Laake, L. W., den Ouden, K., Schreurs, C., Szuhai, K., et al. (2009). Human cardiomyocyte progenitor cell transplantation preserves long-term function of the infarcted mouse myocardium. Cardiovascular Research, 83, 527–535.
50. Vanelli, A., Pennarossa, G., Maffei, S., Galvez, B. G., Cossu, G., et al. (2012). Isolation, characterization and differentiation potential of cardiac progenitor cells in adult pigs. Stem Cell Reviews, 8, 706–719.
51. Martin, C. M., Meeson, A. P., Robertson, S. M., Hawke, T. J., Richardson, J. A., et al. (2004). Persistent expression of the ATPbinding cassette transporter, Abcg2, identifies cardiac SP cells in the developing and adult heart. Developmental Biology, 265, 262–275.
52. Pfister, O., Mouquet, F., Jain, M., Summer, R., Helmes, M., et al. (2005). CD31- but Not CD31+ cardiac side population cells exhibit functional cardiomyogenic differentiation. Circulation Research, 97, 52–61.
53. Matsuura, K., Yoshioka, S., Tosha, T., Hori, H., Ishimori, K., et al. (2005). Structural diversities of active site in clinical azole-bound forms between sterol 14alpha-demethylases (CYP51s) from human and Mycobacterium tuberculosis. The Journal of Biological Chemistry, 280, 9088–9096.
54. Bearzi, C., Rota, M., Hosoda, T., Tillmanns, J., Nascimbene, A., et al. (2007). Human cardiac stem cells. Proc Natl Acad Sci USA, 104(35), 14068–73.
55. Bu, L., Jiang, X., Martin-Puig, S., Caron, L., Zhu, S., et al. (2009). Human ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages. Nature, 460, 113–117.
56. Pfister, O., Oikonomopoulos, A., Sereti, K. I., & Liao, R. (2010). Isolation of resident cardiac progenitor cells by Hoechst 33342 staining. Methods in Molecular Biology, 660, 53–63.
57. Hierlihy, A. M., Seale, P., Lobe, C. G., Rudnicki, M. A., & Megeney, L. A. (2002). The post-natal heart contains a myocardial stem cell population. FEBS Letters, 530, 239–243.
58. Smith, R. R., Barile, L., Cho, H. C., Leppo, M. K., Hare, J. M., et al. (2007). Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation, 115, 896–908.
59. Cai, C. L., Martin, J. C., Sun, Y., Cui, L., Wang, L., et al. (2008). A myocardial lineage derives from Tbx18 epicardial cells. Nature, 454, 104–108.
60. Castaldo, C., Di Meglio, F., Nurzynska, D., Romano, G., Maiello, C., et al. (2008). CD117-positive cells in adult human heart are localized in the subepicardium, and their activation is associated with laminin-1 and alpha6 integrin expression. Stem Cells, 26, 1726–1731.
61. Barile, L., Chimenti, I., Gaetani, R., Forte, E., Miraldi, F., et al. (2007). Cardiac stem cells: isolation, expansion and experimental use for myocardial regeneration. Nature Clinical Practice. Cardiovascular Medicine, 4(Suppl 1), S9–S14.
62. Bolli, P., & Chaudhry, H. W. (2010). Molecular physiology of cardiac regeneration. Annals of the New York Academy of Sciences, 1211, 113–126.
63. Bollini, S., Smart, N., & Riley, P. R. (2011). Resident cardiac progenitor cells: at the heart of regeneration. Journal of Molecular and Cellular Cardiology, 50, 296–303.
64. Di Felice, V., Ardizzone, N. M., De Luca, A., Marciani, V., Marino Gammazza, A., et al. (2009). OPLA scaffold, collagen I, and horse serum induce a higher degree of myogenic differentiation of adult rat cardiac stem cells. Journal of Cellular Physiology, 221, 729–739.
65. Forte, G., Carotenuto, F., Pagliari, F., Pagliari, S., Cossa, P., et al. (2008). Criticality of biological and physical stimuli array inducing resident cardiac stem cell determination. Stem Cells, 26, 2093–2103.
66. Leri, A., Kajstura, J., & Anversa, P. (2011). Role of cardiac stem cells in cardiac pathophysiology: a paradigm shift in human myocardial biology. Circulation Research, 109, 941–961.
67. Di Nardo, P., Forte, G., Ahluwalia, A., & Minieri, M. (2010). Cardiac progenitor cells: potency and control. Journal of Cellular Physiology, 224, 590–600.
68. Di Felice, V., De Luca, A., Colorito, M. L., Montalbano, A., Ardizzone, N. M., et al. (2009). Cardiac stem cell research: an elephant in the room? The Anatomical Record, 292, 449–454.
69. Ellison, G. M., Galuppo, V., Vicinanza, C., Aquila, I., Waring, C. D., et al. (2010). Cardiac stem and progenitor cell identification: different markers for the same cell? Frontiers in Bioscience (Scholar Edition), 2, 641–652.
70. Ellison, G. M., Torella, D., Karakikes, I., & Nadal-Ginard, B. (2007). Myocyte death and renewal: modern concepts of cardiac cellular homeostasis. Nature Clinical Practice. Cardiovascular Medicine, 3(Suppl 1), S8–13.
71. Bearzi, C., Leri, A., Lo Monaco, F., Rota, M., Gonzalez, A., et al. (2009). Identification of a coronary vascular progenitor cell in the human heart. Proceedings of the National Academy of Sciences of the United States of America, 106, 15885–15890.
72. Potten, C. S., & Loeffler, M. (1990). Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the crypt. Development, 110, 1001–1020.
73. Mishra, R., Vijayan, K., Colletti, E. J., Harrington, D. A., Matthiesen, T. S., et al. (2011). Characterization and functionality of cardiac progenitor cells in congenital heart patients. Circulation, 123, 364–373.
74. Itzhaki-Alfia, A., Leor, J., Raanani, E., Sternik, L., Spiegelstein, D., et al. (2009). Patient characteristics and cell source determine the number of isolated human cardiac progenitor cells. Circulation, 120, 2559–2566.
75. Sandstedt, J., Jonsson, M., Lindahl, A., Jeppsson, A., & Asp, J. (2010). C-kit+CD45- cells found in the adult human heart represent a population of endothelial progenitor cells. Basic Research in Cardiology, 105, 545–556.
76. Kuhn, E. N., & Wu, S. M. (2010). Origin of cardiac progenitor cells in the developing and postnatal heart. Journal of Cellular Physiology, 225, 321–325.
77. Zhou, Y., Pan, P., Yao, L., Su, M., He, P., et al. (2010). CD117- positive cells of the heart: progenitor cells or mast cells? The Journal of Histochemistry and Cytochemistry, 58, 309–316.
78. D'Amario, D., Fiorini, C., Campbell, P. M., Goichberg, P., Sanada, F., et al. (2011). Functionally competent cardiac stem cells can be isolated from endomyocardial biopsies of patients with advanced cardiomyopathies. Circulation Research, 108(7), 857–61. doi:101161/CIRC.
79. Rota, M., LeCapitaine, N., Hosoda, T., Boni, A., De Angelis, A., et al. (2006). Diabetes promotes cardiac stem cell aging and heart failure, which are prevented by deletion of the p66shc gene. Circulation Research, 99(1), 42–52.
80. Hong, K. U., Li, Q. H., Guo, Y., Patton, N. S., Moktar, A., et al. (2013). A highly sensitive and accurate method to quantify absolute numbers of c-kit+cardiac stem cells following transplantation in mice. Basic Research in Cardiology, 108, 346.
81. Nelson, T. J., Faustino, R. S., Chiriac, A., Crespo-Diaz, R., Behfar, A., et al. (2008). CXCR4+/FLK-1+ biomarkers select a cardiopoietic lineage from embryonic stem cells. Stem Cells, 26, 1464–1473.
82. Xiao, J., Liang, D., Zhang, H., Liu, Y., Zhang, D., et al. (2012). MicroRNA-204 is required for differentiation of human-derived cardiomyocyte progenitor cells. Journal of Molecular and Cellular Cardiology, 53, 751–759.
83. Moretti, A., Caron, L., Nakano, A., Lam, J. T., Bernshausen, A., et al. (2006). Multipotent embryonic isl1+ progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification. Cell, 127, 1151.
84. Cai, C. L., Liang, X., Shi, Y., Chu, P. H., Pfaff, S. L., et al. (2003). Isl1 identifies a cardiac progenitor population that proliferates prior to differentiation and contributes a majority of cells to the heart. Developmental Cell, 5, 877–889.
85. Dodou, E., Verzi, M. P., Anderson, J. P., Xu, S. M., & Black, B. L. (2004). Mef2c is a direct transcriptional target of ISL1 and GATA factors in the anterior heart field during mouse embryonic development. Development, 131, 3931–3942.
86. Leri, A. (2009). Human cardiac stem cells: the heart of a truth. Circulation, 120, 2515–2518.
87. Minasi, M. G., Riminucci, M., De Angelis, L., Borello, U., Berarducci, B., et al. (2002). The meso-angioblast: a multipotent, self-renewing cell that originates from the dorsal aorta and differentiates into most mesodermal tissues. Development, 129, 2773–2783.
88. Berry, S. E., Liu, J., Chaney, E. J., & Kaufman, S. J. (2007). Multipotential mesoangioblast stem cell therapy in the mdx/utrn-/- mouse model for Duchenne muscular dystrophy. Regenerative Medicine, 2, 275–288.
89. Morosetti, R., Mirabella, M., Gliubizzi, C., Broccolini, A., Sancricca, C., et al. (2007). Isolation and characterization of mesoangioblasts from facioscapulohumeral muscular dystrophy muscle biopsies. Stem Cells, 25, 3173–3182.
90. Sampaolesi, M., Blot, S., D'Antona, G., Granger, N., Tonlorenzi, R., et al. (2006). Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs. Nature, 444, 574–579.
91. Wang, L., Kamath, A., Frye, J., Iwamoto, G. A., Chun, J. L., et al. (2012). Aorta-derived mesoangioblasts differentiate into the oligodendrocytes by inhibition of the Rho kinase signaling pathway. Stem Cells and Development, 21, 1069–1089.
92. Nees, S., Weiss, D. R., & Juchem, G. (2013). Focus on cardiac pericytes. Pflügers Archiv, 465, 779–787.
93. Matsuura, K., Honda, A., Nagai, T., Fukushima, N., Iwanaga, K., et al. (2009). Transplantation of cardiac progenitor cells ameliorates cardiac dysfunction after myocardial infarction in mice. The Journal of Clinical Investigation, 119, 2204–2217.
94. Lee, T. H., D'Asti, E., Magnus, N., Al-Nedawi, K., Meehan, B., et al. (2011). Microvesicles as mediators of intercellular communication in cancer–the emerging science of cellular 'debris'. Seminars in Immunopathology, 33, 455–467.
95. Martin-Puig, S., Wang, Z., & Chien, K. R. (2008). Lives of a heart cell: tracing the origins of cardiac progenitors. Cell Stem Cell, 2, 320–331.
96. Pfister, O., Oikonomopoulos, A., Sereti, K. I., Sohn, R. L., Cullen, D., et al. (2008). Role of the ATP-binding cassette transporter Abcg2 in the phenotype and function of cardiac side population cells. Circulation Research, 103, 825–835.
97. Ishii, Y., Garriock, R. J., Navetta, A. M., Coughlin, L. E., & Mikawa, T. (2010). BMP signals promote proepicardial protrusion necessary for recruitment of coronary vessel and epicardial progenitors to the heart. Developmental Cell, 19, 307–316.
98. Zhou, B., Ma, Q., Rajagopal, S., Wu, S. M., Domian, I., et al. (2008). Epicardial progenitors contribute to the cardiomyocyte lineage in the developing heart. Nature, 454, 109–113.
99. Martínez-Estrada, O. M., Lettice, L. A., Essafi, A., Guadix, J. A., Slight, J., et al. (2010). Wt1 is required for cardiovascular progenitor cell formation through transcriptional control of Snail and Ecadherin. Nature Genetics, 42, 89–93.
100. Zhou, B., Honor, L. B., He, H., Ma, Q., Oh, J. H., et al. (2011). Adult mouse epicardium modulates myocardial injury by secreting paracrine factors. The Journal of Clinical Investigation, 121, 1894–1904.
101. Limana, F., Zacheo, A., Mocini, D., Mangoni, A., Borsellino, G., et al. (2007). Identification of myocardial and vascular precursor cells in human and mouse epicardium. Circulation Research, 101, 1255–1265.
102. Wang, J., Panáková, D., Kikuchi, K., Holdway, J. E., Gemberling, M., et al. (2011). The regenerative capacity of zebrafish reverses cardiac failure caused by genetic cardiomyocyte depletion. Development, 138, 3421–3430.
103. Nadal-Ginard, B., Kajstura, J., Leri, A., & Anversa, P. (2003). Myocyte death, growth, and regeneration in cardiac hypertrophy and failure. Circulation Research, 92, 139–150.
104. Saxena, A., Fish, J. E., White, M. D., Yu, S., Smyth, J. W., et al. (2008). Stromal cell-derived factor-1alpha is cardioprotective after myocardial infarction. Circulation, 117, 2224–2231.
105. Chimenti, I., Smith, R. R., Li, T. S., Gerstenblith, G., Messina, E., et al. (2010). Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice. Circulation Research, 106(5), 971–80. doi:101161/CIRCRESA.
106. Miyamoto, S., Kawaguchi, N., Ellison, G. M., Matsuoka, R., Shin'oka, T., et al. (2010). Characterization of long-term cultured c-kit+cardiac stem cells derived from adult rat hearts. Stem Cells and Development, 19, 105–116.
107. Loffredo, F. S., Steinhauser, M. L., Gannon, J., & Lee, R. T. (2011). Bone marrow-derived cell therapy stimulates endogenous cardiomyocyte progenitors and promotes cardiac repair. Cell Stem Cell, 8, 389–398.
108. Leri, A., Kajstura, J., & Anversa, P. (2005). Cardiac stem cells and mechanisms of myocardial regeneration. Physiological Reviews, 85, 1373–1416.
109. Jackson, K. A., Majka, S. M., Wang, H., Pocius, J., Hartley, C. J., et al. (2001). Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. The Journal of Clinical Investigation, 107, 1395–1402.
110. Wollert, K. C., & Drexler, H. (2005). Clinical applications of stem cells for the heart. Circulation Research, 96, 151–163.
111. Amado, L. C., Saliaris, A. P., Schuleri, K. H., St John, M., Xie, J. S., et al. (2005). Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci USA, 102, 11474.
112. Segers, V. F., & Lee, R. T. (2008). Stem-cell therapy for cardiac disease. Nature, 451, 937–942.
113. Tang, X. L., Rokosh, G., Sanganalmath, S. K., Yuan, F., Sato, H., et al. (2010). Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-dayold infarction. Circulation, 121, 293–305.
114. San Martin, N., Cervera, A. M., Cordova, C., Covarello, D., McCreath, K. J., et al. (2011). Mitochondria determine the differentiation potential of cardiac mesoangioblasts. Stem Cells, 29, 1064–1074.
115. Latronico, M. V., & Condorelli, G. (2009). MicroRNAs and cardiac pathology. Nature Reviews Cardiology, 6, 419–429.
116. Brett, J. O., Renault, V. M., Rafalski, V. A., Webb, A. E., & Brunet, A. (2011). The microRNA cluster miR-106b 25 regulates adult neural stem/progenitor cell proliferation and neuronal differentiation. Aging (Albany NY), 3, 108–124.
117. Glass, C., & Singla, D. K. (2011). ES cells overexpressing microRNA-1 attenuate apoptosis in the injured myocardium. Molecular and Cellular Biochemistry, 357, 135–141.
118. Juan, A. H., & Sartorelli, V. (2010). MicroRNA-214 and polycomb group proteins: a regulatory circuit controlling differentiation and cell fate decisions. Cell Cycle, 9(8), 1445–6.
119. Bauersachs, J. (2010). Regulation of myocardial fibrosis by MicroRNAs. Journal of Cardiovascular Pharmacology, 56, 454–459.
120. Wang, Y., Baskerville, S., Shenoy, A., Babiarz, J. E., Baehner, L., et al. (2008). Embryonic stem cell-specific microRNAs regulate the G1-S transition and promote rapid proliferation. Nature Genetics, 40, 1478–1483.
121. Martinez, N. J., & Gregory, R. I. (2010). MicroRNA gene regulatory pathways in the establishment and maintenance of ESC identity. Cell Stem Cell, 7, 31–35.
122. Sluijter, J. P. G., van MIl, A., van Vliet, P., Metz, C. H. G., Liu, J., et al. (2010). MicroRna-1 and -499 regulate differentiation and proliferation in human-derived cardiomyocyte progenitor cells. ATVB, 30, 859–868.
123. Eulalio, A., Mano, M., Dal Ferro, M., Zentilin, L., Sinagra, G., et al. (2012). Funtional screening identifes miRNAs inducing cardiac regeneration. Nature, 492, 376–381.
124. Divakaran, V., & Mann, D. L. (2008). The emerging role of microRNAs in cardiac remodeling and heart failure. Circulation Research, 103, 1072–1083.
125. Sluijter, J. P., van Mil, A., van Vliet, P., Metz, C. H., Liu, J., et al. (2010). MicroRNA-1 and -499 regulate differentiation and proliferation in human-derived cardiomyocyte progenitor cells. Arteriosclerosis, Thrombosis, and Vascular Biology, 30, 859–868.
126. Heinrich, E. M., & Dimmeler, S. (2012). MicroRNAs and stem cells: control of pluripotency, reprogramming, and lineage commitment. Circulation Research, 110, 1014–1022.
127. Subramanyam, D., Lamouille, S., Judson, R. L., Liu, J. Y., Bucay, N., et al. (2011). Multiple targets of miR-302 and miR-372 promote reprogramming of human fibroblasts to induced pluripotent stem cells. Nature Biotechnology, 29, 443–448.
128. Jayawardena, T. M., Egemnazarov, B., Finch, E. A., Zhang, L., Payne, J. A., et al. (2012).MicroRNA-mediated in vitro and in vivo direct reprogramming of cardiac fibroblasts to cardiomyocytes. Circulation Research, 110, 1465–1473.
129. Biancone, L., Bruno, S., Deregibus, M. C., Tetta, C., & Camussi, G. (2012). Therapeutic potential of mesenchymal stem cell-derived microvesicles. Nephrology, Dialysis, Transplantation, 27, 3037–3042.
130. Stoorvogel, W. (2012). Functional transfer of microRNA by exosomes. Blood, 119, 646–648.
131. Roubille, F., Franck-Miclo, A., Covinhes, A., Lafont, C., Cransac, F., et al. (2011). Delayed postconditioning in the mouse heart in vivo. Circulation, 124, 1330–1336.
132. Palumbo, R., Galvez, B. G., Pusterla, T., De Marchis, F., Cossu, G., et al. (2007). Cells migrating to sites of tissue damage in response to the danger signal HMGB1 require NF-kappaB activation. The Journal of Cell Biology, 179, 33–40.
133. Bernal, A., San Martín, N., Fernández, M., Covarello, D., Molla, F., et al. (2012). L-selectin and SDF-1 enhance the migration of mouse and human cardiac mesoangioblasts. Cell Death and Differentiation, 19, 345–355.
134. Galvez, B. G., Sampaolesi, M., Brunelli, S., Covarello, D., Gavina, M., et al. (2006). Complete repair of dystrophic skeletal muscle by mesoangioblasts with enhanced migration ability. The Journal of Cell Biology, 174, 231–243.
135. Frishman, W. H. (2013). β-Adrenergic Blockade in Cardiovascular Disease. Journal of Cardiovascular Pharmacology and Therapeutics.
136. Kral, B. G., & Kraitchman, D. L. (2013). From Mice to Men: Gene Therapy's Future for Treatment of Myocardial Infarction. Circulation. Cardiovascular Imaging, 6, 360–362.
137. Christman, K. L., & Lee, R. J. (2006). Biomaterials for the treatment of myocardial infarction. Journal of the American College of Cardiology, 48, 907–913.
138. Sreejit, P., & Verma, R. S. (2013). Natural ECM as biomaterial for scaffold based cardiac regeneration using adult bone marrow derived stem cells. Stem Cell Reviews, 9, 158–171.
139. Chai, C., & Leong, K. W. (2007). Biomaterials approach to expand and direct differentiation of stem cells. Molecular Therapy, 15, 467–480.
140. Di Felice, V., Serradifalco, C., Rizzuto, L., De Luca, A., Rappa, F., et al. (2013). Silk fibroin scaffolds enhance cell commitment of adult rat cardiac progenitor cells. Journal of Tissue Engineering and Regenerative Medicine.
141. Syedain, Z. H., Bradee, A. R., Kren, S., Taylor, D. A., & Tranquillo, R. T. (2013). Decellularized tissue-engineered heart valve leaflets with recellularization potential. Tissue Engineering Part A, 19, 759–769.
142. Takeuchi, J. K., & Bruneau, B. G. (2009). Directed transdifferentiation of mouse mesoderm to heart tissue by defined factors. Nature, 459, 708–711.
143. Kattman, S. J., Witty, A. D., Gagliardi, M., Dubois, N. C., Niapour, M., et al. (2011). Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines. Cell Stem Cell, 8, 228–240.
144. Ieda, M., Fu, J. D., Delgado-Olguin, P., Vedantham, V., Hayashi, Y., et al. (2010). Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell, 142, 375–386.
145. Sinnecker, D., Goedel, A., Laugwitz, K. L., & Moretti, A. (2013). Induced pluripotent stem cell-derived cardiomyocytes: a versatile tool for arrhythmia research. Circulation Research, 1125, 961–968.
146. Burridge, P. W., Keller, G., Gold, J. D., & Wu, J. C. (2012). Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming. Cell Stem Cell, 10, 16–28.
147. Efe, J. A., Yuan, X., Jiang, K., & Ding, S. (2011). Development unchained: how cellular reprogramming is redefining our view of cell fate and identity. Science Progress, 94, 298–322.
148. Bolli, R., Chugh, A. R., D'Amario, D., Loughran, J. H., Stoddard, M. F., et al. (2011). Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet, 378, 1847–1857.
149. Assmus, B., Walter, D. H., Seeger, F. H., Leistner, D. M., Steiner, J., et al. (2013). Effect of shock wave-facilitated intracoronary cell therapy on LVEF in patients with chronic heart failure: the CELLWAVE randomized clinical trial. Journal of the American Medical Association, 309, 1622–1631.
150. Janssens, S., Dubois, C., Bogaert, J., Theunissen, K., Deroose, C., et al. (2006). Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet, 367, 113–121.
151. Beltrami, A. P., Cesselli, D., Bergamin, N., Marcon, P., Rigo, S., et al. (2007). Multipotent cells can be generated in vitro from several adult human organs (heart, liver, and bone marrow). Blood, 110, 3438–3446.
152. Britten, M. B., Abolmaali, N. D., Assmus, B., Lehmann, R., Honold, J., et al. (2003). Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCAREAMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging. Circulation, 108, 2212–2218.
153. Stamm, C., Westphal, B., Kleine, H. D., Petzsch, M., Kittner, C., et al. (2003). Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet, 361, 45–46.
154. Perin, E. C., Dohmann, H. F., Borojevic, R., Silva, S. A., Sousa, A. L., et al. (2003). Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation, 107(18), 2294–302.
155. Tse, H. F., Kwong, Y. L., Chan, J.K., Lo, G., Ho, C. L., et al. (2003). Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet, 361(9351), 47–9.
156. Abdel-Latif, A., Bolli, R., Tleyjeh, I. M., Montori, V. M., Perin, E. C., et al. (2007). Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Archives of Internal Medicine, 167, 989–997.
157. Erbs, S., Linke, A., Schächinger, V., Assmus, B., Thiele, H., et al. (2007). Restoration of microvascular function in the infarct-related artery by intracoronary transplantation of bone marrow progenitor cells in patients with acute myocardial infarction: the Doppler Substudy of the Reinfusion of Enriched Progenitor Cells and Infarct Remodeling in Acute Myocardial Infarction (REPAIR-AMI) trial. Circulation, 116, 366–374.
158. Menasché, P. (2008). Cardiac cell therapy trials: chronic myocardial infarction and congestive heart failure. Journal of Cardiovascular Translational Research, 1, 201–206.
159. Aicher, A., Heeschen, C., Sasaki, K., Urbich, C., Zeiher, A. M., et al. (2006). Low-energy shock wave for enhancing recruitment of endothelial progenitor cells: a new modality to increase efficacy of cell therapy in chronic hind limb ischemia. Circulation, 114, 2823–2830.
160. Trachtenberg, B., Velazquez, D. L., Williams, A. R., McNiece, I., Fishman, J., et al. (2011). Rationale and design of the Transendocardial Injection of Autologous Human Cells (bone marrow and mesenchymal) in Chronic Ischemic Left Ventricular Dysfunction and Heart Failure Secondary to Myocardial Infarction (TAC-HFT) trial: A randomized, double-blind, placebo-controlled study of safety and efficacy. American Heart Journal, 161, 487–493.
161. Bartunek, J., Behfar, A., Dolatabadi, D., Vanderheyden, M., Ostojic, M., et al. (2013). Cardiopoietic stem cell therapy in heart failure The C-CURE multicenter randomized trial with lineagespecified biologics. Journal of the American College of Cardiology, S0735–1097, 01397–01391.
162. Chugh, A. R., Beache, G. M., Loughran, J. H., Mewton, N., Elmore, J. B., et al. (2012). Administration of cardiac stem cells in patients with ischemic cardiomyopathy: the SCIPIO trial: surgical aspects and interim analysis of myocardial function and viability by magnetic resonance. Circulation, 126, S54–64.